Lista de obras - Chun-Jen Liu - Dominio Público Uruguay

Addition of ribavirin to daclatasvir plus asunaprevir for chronic hepatitis C 1b patients with baseline NS5A resistance-associated variants improved response.

artículo científico publicado en 2016

Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence

artículo científico publicado en 2014

Age and gender may be the key points in hyperglycemic patients with Helicobacter pylori infection combined colorectal adenoma.

artículo científico publicado en 2018

Amebic liver abscess and human immunodeficiency virus infection: a report of three cases.

artículo científico publicado en 2001

Androgen receptor exon 1 CAG repeat length and risk of hepatocellular carcinoma in women

artículo científico publicado en 2002

Asian consensus on the relationship between obesity and gastrointestinal and liver diseases

artículo científico publicado en 2016

Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.

artículo científico publicado en 2015

Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update

artículo científico publicado en 2012

Associated factors and clinical implications of serum aminotransferase elevation in scrub typhus

artículo científico publicado en 2014

Association of chronic hepatitis B virus infection with insulin resistance and hepatic steatosis.

artículo científico publicado en 2007

Characterization of interleukin 8 in woodchucks with chronic hepatitis B and hepatocellular carcinoma.

artículo científico publicado en 2008

Characterization of metastatic tumor antigen 1 and its interaction with hepatitis B virus X protein in NF-κB signaling and tumor progression in a woodchuck hepatocellular carcinoma model

scientific article published on 13 June 2016

Chronic hepatitis B is associated with an increased risk of B-cell non-Hodgkin's lymphoma and multiple myeloma

scientific article published on 25 January 2019

Circulating programmed death-1 as a marker for sustained high hepatitis B viral load and risk of hepatocellular carcinoma

artículo científico publicado en 2014

Clinical and Histologic Features of Patients with Biopsy-Proven Metabolic Dysfunction-Associated Fatty Liver Disease

artículo científico publicado en 2021

Clinical aspects and outcomes of volunteer blood donors testing positive for hepatitis-C virus infection in Taiwan: a prospective study.

artículo científico publicado en 2003

Clinical characteristics and long-term outcome of acute kidney injury in patients with HBV-related acute-on-chronic liver failure.

artículo científico publicado en 2016

Clinical presentations of patients from different age cohorts with biliary tract stone diseases

Clinical significance and evolution of hepatic HBsAg expression in HBeAg-positive patients receiving interferon therapy

artículo científico publicado en 2013

Clinical significance of occult hepatitis B virus infection cannot be overlooked.

artículo científico publicado en 2006

Clinicopathological differences between hepatitis B viral genotype B- and C-related resectable hepatocellular carcinoma.

artículo científico publicado en 2007

Combination Therapy for Chronic Hepatitis B: Current Updates and Perspectives

artículo científico publicado en 2017

Commentary: treatment of hepatitis C-related cirrhosis in the era of direct-acting anti-virals

artículo científico publicado en 2014

Community and personal risk factors for hepatitis C virus infection: a survey of 23,820 residents in Taiwan in 1991-2.

artículo científico publicado en 2010

Comparison of a 6-month course peginterferon alpha-2b plus ribavirin and interferon alpha-2b plus ribavirin in treating Chinese patients with chronic hepatitis C in Taiwan.

artículo científico publicado en 2005

Consensus cost-effectiveness model for treatment of chronic hepatitis B in Asia Pacific countries

artículo científico

Consolidation therapy for HBeAg-positive Asian chronic hepatitis B patients receiving lamivudine treatment: a multicentre study

artículo científico publicado en 2013

Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study.

artículo científico publicado en 2009

Decreased neonatal hepatitis B virus (HBV) viremia by maternal tenofovir treatment predicts reduced chronic HBV infection in children born to highly viremic mothers

scientific article published on 04 July 2019

Development of risk scoring system for stratifying population for hepatocellular carcinoma screening.

artículo científico publicado en 2015

Discontinuation of lamivudine treatment for hepatitis flare after kidney or heart transplantation in hepatitis B surface antigen-positive patients: A retrospective case series.

artículo científico publicado en 2006

Disease Progression in a Patient with Nonalcoholic Steatohepatitis

article

Dynamics of hepatitis B e antigen index ratio correlate with treatment response in chronic hepatitis B patients

article

Early antiviral therapy reduces the risk of lymphoma in patients with chronic hepatitis C infection

scientific article published on 27 December 2018

Early viral kinetics during treatment of chronic hepatitis C virus infection with pegylated interferon alpha plus ribavirin in Taiwan.

artículo científico publicado en 2007

Efficacy of Ledipasvir and Sofosbuvir Treatment of HCV Infection in Patients Coinfected with HBV.

artículo científico publicado en 2017

End-of-treatment virologic response does not predict relapse after lamivudine treatment for chronic hepatitis B.

artículo científico publicado en 2004

Epidemiology of HBV infection in Asian blood donors: emphasis on occult HBV infection and the role of NAT.

artículo científico publicado en 2006

Erratum to: Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update

artículo científico publicado en 2012

Evolution of Hepatitis B virus in an acute hepatitis B patient co-infected with genotypes B and C.

artículo científico publicado en 2006

Evolution of precore/core promoter mutations in hepatitis B carriers with hepatitis B e antigen seroreversion.

artículo científico publicado en 2004

Fibrosis-4 index predicts cirrhosis risk and liver-related mortality in 2075 patients with chronic HBV infection.

artículo científico publicado en 2018

Fine mapping of hepatitis B virus pre-S deletion and its association with hepatocellular carcinoma.

artículo científico publicado en 2012

Generic velpatasvir plus sofosbuvir for hepatitis C virus infection in patients with or without human immunodeficiency virus coinfection.

artículo científico publicado en 2018

Global perspective on the natural history of chronic hepatitis B: role of hepatitis B virus genotypes A to J.

artículo científico

Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: A randomized phase II trial for safety and optimal dosage

artículo científico publicado en 2009

Hepatitis B genotypes and precore/basal core promoter mutants in HBeAg-negative chronic hepatitis B

artículo científico publicado en 2002

Hepatitis B genotypes correlate with tumor recurrence after curative resection of hepatocellular carcinoma.

artículo científico publicado en 2004

Hepatitis B viral factors in HBeAg-Negative carriers with persistently normal serum alanine aminotransferase levels

scientific article published on 01 May 2007

Hepatitis B viral genotypes and lamivudine resistance.

artículo científico publicado en 2002

Hepatitis B virus basal core promoter mutation and DNA load correlate with expression of hepatitis B core antigen in patients with chronic hepatitis B.

artículo científico publicado en 2009

Hepatitis B virus core variants modify natural course of viral infection and hepatocellular carcinoma progression.

artículo científico publicado en 2009

Hepatitis B virus genotype B has an earlier emergence of lamivudine resistance than genotype C.

artículo científico publicado en 2009

Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men.

artículo científico publicado en 2005

Hepatitis B virus reactivation in patients receiving cancer chemotherapy: natural history, pathogenesis, and management

artículo científico publicado en 2011

Hepatitis C virus infection and increased risk of cerebrovascular disease.

artículo científico publicado en 2010

Hepatitis C virus reinfection in people living with human immunodeficiency virus in Taiwan after achieving sustained virologic response with antiviral treatment: the RECUR study

artículo científico publicado en 2022

Hepatitis C virus seromarkers and subsequent risk of hepatocellular carcinoma: long-term predictors from a community-based cohort study

artículo científico publicado en 2010

High prevalence of mixed genotype infections in hepatitis B virus infected intravenous drug users.

artículo científico publicado en 2004

Host genetic factors affecting spontaneous HBsAg seroclearance in chronic hepatitis B patients

artículo científico publicado en 2013

Host genetic variants and hepatitis B virologic features in HBeAg-negative hepatitis B carriers with long-term biochemical remission ⬇️

artículo científico publicado el 21 de julio de 2011

Human leukocyte antigen-DRB1*1101 correlates with less severe hepatitis in Taiwanese male carriers of hepatitis B virus.

artículo científico publicado en 2009

Impact of genetic heterogeneity in polymerase of hepatitis B virus on dynamics of viral load and hepatitis B progression

artículo científico publicado en 2013

Impact of occult hepatitis B on the clinical outcomes of patients with chronic hepatitis C virus infection: A 10-year follow-up

artículo científico publicado en 2016

Increased incidence of gastroesophageal reflux disease in patients with chronic hepatitis B virus infection ⬇️

artículo científico publicado el 1 de julio de 2010

Increased risk for hepatitis B-related liver cirrhosis in relatives of patients with hepatocellular carcinoma in northern Taiwan

artículo científico publicado en 2002

Increased risk of hepatocellular carcinoma in chronic hepatitis C patients with new onset diabetes: a nation-wide cohort study.

artículo científico publicado en 2015

Influence of Metabolic Risk Factors on Risk of Hepatocellular Carcinoma and Liver-related Death in Men with Chronic Hepatitis B: A Large Cohort Study.

artículo científico

Influences of tobacco and alcohol use on hepatocellular carcinoma survival

artículo científico publicado en 2012

Insulin, glucose and hepatocellular carcinoma risk in male hepatitis B carriers: results from 17-year follow-up of a population-based cohort ⬇️

artículo científico publicado el 3 de abril de 2011

Interferon alpha-2b with and without ribavirin in the treatment of hepatitis B e antigen-positive chronic hepatitis B: a randomized study.

artículo científico publicado en 2006

Lamivudine treatment for hepatitis B reactivation in HBsAg carriers after organ transplantation: a 4-year experience.

artículo científico publicado en 2001

Liver Gene Expression Profiles Correlate with Virus Infection and Response to Interferon Therapy in Chronic Hepatitis B Patients

artículo científico publicado en 2016

Localization of a susceptibility locus for hepatocellular carcinoma to chromosome 4q in a hepatitis B hyperendemic area

artículo científico publicado en 2006

Long-term Effects of Hepatitis B Immunization of Infants in Preventing Liver Cancer

artículo científico publicado en 2016

Long-term effect of interferon plus ribavirin on hepatitis B surface antigen seroclearance in patients dually infected with hepatitis B and C viruses.

artículo científico publicado en 2011

Longitudinal change of HBsAg in HBeAg-negative patients with genotype B or C infection

artículo científico publicado en 2013

Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan.

artículo científico publicado en 2008

Metabolic syndrome on top of chronic hepatitis B: the more, the worse?

scientific article published on 01 February 2010

Milder clinical manifestation of scrub typhus in Kinmen, Taiwan

artículo científico publicado en 2012

Molecular Epidemiology of Hepatitis B Viral Serotypes and Genotypes in Taiwan

artículo científico publicado en 2002

Molecular assays for hepatitis B virus infection.

artículo científico publicado en 2003

Molecular mechanism and treatment of viral hepatitis-related liver fibrosis

artículo científico publicado en 2014

More than a virus: a qualitative study of the social implications of hepatitis B infection in China.

artículo científico publicado en 2017

Mother-to-infant transmission of hepatitis B virus: challenges and perspectives.

artículo científico publicado en 2017

NOhep: Toward Global Control of Hepatitis B Virus Infection-An Introduction

artículo científico publicado en 2017

Natural course and treatment of hepatitis D virus infection.

artículo científico publicado en 2006

Origin of serum hepatitis B virus in acute exacerbation: comparison with HBV in the liver and from other exacerbation.

artículo científico publicado en 2004

Overlap lamivudine treatment in patients with chronic hepatitis B receiving adefovir for lamivudine-resistant viral mutants

artículo científico publicado en 2006

Paritaprevir/ritonavir, ombitasvir plus dasabuvir for East Asian non-cirrhotic hepatitis C virus genotype 1b patients receiving hemodialysis

artículo científico publicado en 2019

Peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses

artículo científico publicado en 2008

Perspectives on dual hepatitis B and C infection in Taiwan

artículo científico publicado en 2016

Plasma adipokines and risk of hepatocellular carcinoma in chronic hepatitis B virus-infected carriers: a prospective study in taiwan

artículo científico publicado en 2014

Prevalence and clinical implications of HFE gene mutations (C282Y and H63D) in patients with chronic hepatitis B and C in Taiwan.

artículo científico publicado en 2005

Prevalence and risk factors for non-alcoholic fatty liver disease in Asian people who are not obese.

artículo científico publicado en 2012

Progressive accumulation of mutations in the hepatitis B virus genome and its impact on time to diagnosis of hepatocellular carcinoma.

artículo científico publicado en 2016

Quantification and genotyping of hepatitis B virus in a single reaction by real-time PCR and melting curve analysis

artículo científico publicado en 2004

RNA interference-mediated control of hepatitis B virus and emergence of resistant mutant.

artículo científico publicado en 2005

Rapid Prediction of Treatment Futility of Boceprevir with Peginterferon-Ribavirin for Taiwanese Treatment Experienced Hepatitis C Virus Genotype 1-Infected Patients.

artículo científico publicado en 2015

Reactivation of hepatitis B virus in an inactive hepatitis B carrier with glucocorticoid pulse therapy.

artículo científico publicado en 2008

Ribavirin and interferon is effective for hepatitis C virus clearance in hepatitis B and C dually infected patients

artículo científico publicado en 2003

Role of reproductive factors in hepatocellular carcinoma: Impact on hepatitis B- and C-related risk

artículo científico publicado en 2003

Sequential combination therapy for chronic hepatitis B: more challenges to be tackled

scientific article published on 01 July 2007

Serum adiponectin correlates with viral characteristics but not histologic features in patients with chronic hepatitis C.

artículo científico publicado en 2005

Serum hepatitis B surface antigen levels predict surface antigen loss in hepatitis B e antigen seroconverters.

artículo científico publicado en 2011

Serum hepatitis B virus-DNA levels correlate with long-term adverse outcomes in spontaneous hepatitis B e antigen seroconverters.

artículo científico publicado en 2011

Significance of definitions of relapse after discontinuation of oral antivirals in HBeAg-negative chronic hepatitis B.

artículo científico publicado en 2017

Sorafenib and its derivative SC-1 exhibit antifibrotic effects through signal transducer and activator of transcription 3 inhibition

artículo científico publicado en 2015

Subgenotypes of hepatitis B virus genotype C do not correlate with disease progression of chronic hepatitis B in Taiwan.

artículo científico publicado en 2007

Subgenotypes of hepatitis B virus genotype C in Taiwan.

artículo científico publicado en 2005

The Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017-Part 2: Management and special groups.

artículo científico publicado en 2017

The Asia-Pacific Working Party on Nonalcoholic Fatty Liver Disease Guidelines 2017 Part 1: Definition, risk factors and assessment

artículo científico publicado en 2017

The CRISPR/Cas9 System Facilitates Clearance of the Intrahepatic HBV Templates In Vivo

artículo científico publicado en 2014

The clinical significance of occult hepatitis B transfusion in Taiwan--a look-back study.

artículo científico

The non-structural 5A protein of hepatitis C virus exhibits genotypic differences in interferon antagonism.

artículo científico publicado en 2008

The risky body mass index ranges for significant hepatitis B viral load: A campus-based study

artículo científico publicado en 2012

Therapeutic implications of hepatitis B virus genotypes.

artículo científico publicado en 2005

Transmission of occult hepatitis B virus by transfusion to adult and pediatric recipients in Taiwan

artículo científico publicado en 2005

Treatment of patients with dual hepatitis C and B by peginterferon α and ribavirin reduced risk of hepatocellular carcinoma and mortality.

artículo científico publicado en 2013

Treatment of patients with dual hepatitis C virus and hepatitis B virus infection: resolved and unresolved issues

artículo científico publicado en 2014

Updates on the treatment and outcomes of dual chronic hepatitis C and B virus infection.

artículo científico publicado en 2014

Viral Factors Affecting the Clinical Outcomes of Chronic Hepatitis B.

artículo científico publicado en 2017

Vitamin D receptor gene polymorphisms and distinct clinical phenotypes of hepatitis B carriers in Taiwan.

artículo científico publicado en 2009

Lista de obras de Chun-Jen Liu

Addition of ribavirin to daclatasvir plus asunaprevir for chronic hepatitis C 1b patients with baseline NS5A resistance-associated variants improved response.

Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence

Age and gender may be the key points in hyperglycemic patients with Helicobacter pylori infection combined colorectal adenoma.

Amebic liver abscess and human immunodeficiency virus infection: a report of three cases.

Androgen receptor exon 1 CAG repeat length and risk of hepatocellular carcinoma in women

Asian consensus on the relationship between obesity and gastrointestinal and liver diseases

Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update.

Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update

Associated factors and clinical implications of serum aminotransferase elevation in scrub typhus

Association of chronic hepatitis B virus infection with insulin resistance and hepatic steatosis.

Characterization of interleukin 8 in woodchucks with chronic hepatitis B and hepatocellular carcinoma.

Characterization of metastatic tumor antigen 1 and its interaction with hepatitis B virus X protein in NF-κB signaling and tumor progression in a woodchuck hepatocellular carcinoma model

Chronic hepatitis B is associated with an increased risk of B-cell non-Hodgkin's lymphoma and multiple myeloma

Circulating programmed death-1 as a marker for sustained high hepatitis B viral load and risk of hepatocellular carcinoma

Clinical and Histologic Features of Patients with Biopsy-Proven Metabolic Dysfunction-Associated Fatty Liver Disease

Clinical aspects and outcomes of volunteer blood donors testing positive for hepatitis-C virus infection in Taiwan: a prospective study.

Clinical characteristics and long-term outcome of acute kidney injury in patients with HBV-related acute-on-chronic liver failure.

Clinical presentations of patients from different age cohorts with biliary tract stone diseases

Clinical significance and evolution of hepatic HBsAg expression in HBeAg-positive patients receiving interferon therapy

Clinical significance of occult hepatitis B virus infection cannot be overlooked.

Clinicopathological differences between hepatitis B viral genotype B- and C-related resectable hepatocellular carcinoma.

Combination Therapy for Chronic Hepatitis B: Current Updates and Perspectives

Commentary: treatment of hepatitis C-related cirrhosis in the era of direct-acting anti-virals

Community and personal risk factors for hepatitis C virus infection: a survey of 23,820 residents in Taiwan in 1991-2.

Comparison of a 6-month course peginterferon alpha-2b plus ribavirin and interferon alpha-2b plus ribavirin in treating Chinese patients with chronic hepatitis C in Taiwan.

Consensus cost-effectiveness model for treatment of chronic hepatitis B in Asia Pacific countries

Consolidation therapy for HBeAg-positive Asian chronic hepatitis B patients receiving lamivudine treatment: a multicentre study

Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study.

Decreased neonatal hepatitis B virus (HBV) viremia by maternal tenofovir treatment predicts reduced chronic HBV infection in children born to highly viremic mothers

Development of risk scoring system for stratifying population for hepatocellular carcinoma screening.

Discontinuation of lamivudine treatment for hepatitis flare after kidney or heart transplantation in hepatitis B surface antigen-positive patients: A retrospective case series.

Disease Progression in a Patient with Nonalcoholic Steatohepatitis

Dynamics of hepatitis B e antigen index ratio correlate with treatment response in chronic hepatitis B patients

Early antiviral therapy reduces the risk of lymphoma in patients with chronic hepatitis C infection

Early viral kinetics during treatment of chronic hepatitis C virus infection with pegylated interferon alpha plus ribavirin in Taiwan.

Efficacy of Ledipasvir and Sofosbuvir Treatment of HCV Infection in Patients Coinfected with HBV.

End-of-treatment virologic response does not predict relapse after lamivudine treatment for chronic hepatitis B.

Epidemiology of HBV infection in Asian blood donors: emphasis on occult HBV infection and the role of NAT.

Erratum to: Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update

Evolution of Hepatitis B virus in an acute hepatitis B patient co-infected with genotypes B and C.

Evolution of precore/core promoter mutations in hepatitis B carriers with hepatitis B e antigen seroreversion.

Fibrosis-4 index predicts cirrhosis risk and liver-related mortality in 2075 patients with chronic HBV infection.

Fine mapping of hepatitis B virus pre-S deletion and its association with hepatocellular carcinoma.

Generic velpatasvir plus sofosbuvir for hepatitis C virus infection in patients with or without human immunodeficiency virus coinfection.

Global perspective on the natural history of chronic hepatitis B: role of hepatitis B virus genotypes A to J.

Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: A randomized phase II trial for safety and optimal dosage

Hepatitis B genotypes and precore/basal core promoter mutants in HBeAg-negative chronic hepatitis B

Hepatitis B genotypes correlate with tumor recurrence after curative resection of hepatocellular carcinoma.

Hepatitis B viral factors in HBeAg-Negative carriers with persistently normal serum alanine aminotransferase levels

Hepatitis B viral genotypes and lamivudine resistance.

Hepatitis B virus basal core promoter mutation and DNA load correlate with expression of hepatitis B core antigen in patients with chronic hepatitis B.

Hepatitis B virus core variants modify natural course of viral infection and hepatocellular carcinoma progression.

Hepatitis B virus genotype B has an earlier emergence of lamivudine resistance than genotype C.

Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men.

Hepatitis B virus reactivation in patients receiving cancer chemotherapy: natural history, pathogenesis, and management

Hepatitis C virus infection and increased risk of cerebrovascular disease.

Hepatitis C virus reinfection in people living with human immunodeficiency virus in Taiwan after achieving sustained virologic response with antiviral treatment: the RECUR study

Hepatitis C virus seromarkers and subsequent risk of hepatocellular carcinoma: long-term predictors from a community-based cohort study

High prevalence of mixed genotype infections in hepatitis B virus infected intravenous drug users.

Host genetic factors affecting spontaneous HBsAg seroclearance in chronic hepatitis B patients

Host genetic variants and hepatitis B virologic features in HBeAg-negative hepatitis B carriers with long-term biochemical remission ⬇️

Human leukocyte antigen-DRB1*1101 correlates with less severe hepatitis in Taiwanese male carriers of hepatitis B virus.

Impact of genetic heterogeneity in polymerase of hepatitis B virus on dynamics of viral load and hepatitis B progression

Impact of occult hepatitis B on the clinical outcomes of patients with chronic hepatitis C virus infection: A 10-year follow-up

Increased incidence of gastroesophageal reflux disease in patients with chronic hepatitis B virus infection ⬇️

Increased risk for hepatitis B-related liver cirrhosis in relatives of patients with hepatocellular carcinoma in northern Taiwan

Increased risk of hepatocellular carcinoma in chronic hepatitis C patients with new onset diabetes: a nation-wide cohort study.

Influence of Metabolic Risk Factors on Risk of Hepatocellular Carcinoma and Liver-related Death in Men with Chronic Hepatitis B: A Large Cohort Study.

Influences of tobacco and alcohol use on hepatocellular carcinoma survival

Insulin, glucose and hepatocellular carcinoma risk in male hepatitis B carriers: results from 17-year follow-up of a population-based cohort ⬇️

Interferon alpha-2b with and without ribavirin in the treatment of hepatitis B e antigen-positive chronic hepatitis B: a randomized study.

Lamivudine treatment for hepatitis B reactivation in HBsAg carriers after organ transplantation: a 4-year experience.

Liver Gene Expression Profiles Correlate with Virus Infection and Response to Interferon Therapy in Chronic Hepatitis B Patients

Localization of a susceptibility locus for hepatocellular carcinoma to chromosome 4q in a hepatitis B hyperendemic area

Long-term Effects of Hepatitis B Immunization of Infants in Preventing Liver Cancer

Long-term effect of interferon plus ribavirin on hepatitis B surface antigen seroclearance in patients dually infected with hepatitis B and C viruses.

Longitudinal change of HBsAg in HBeAg-negative patients with genotype B or C infection

Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan.

Metabolic syndrome on top of chronic hepatitis B: the more, the worse?